True to form, U.S. pharmaceutical companies are moving forward with mid-year price hikes despite an intense focus by the Trump administration and Congress on lowering treatment costs. Drugmakers tend to hike prices on their prescription medications in January and early July.
Trending:
Big pharma pursues mid-year cost hikes as Trump officials tout drug pricing efforts